Trifecta Aortic Bioprosthesis: Midterm Results in 1,953 Patients From a Single Center

Brown, 2009, Isolated aortic valve replacement in North America comprising 108,687 patients in 10 years: changes in risks, valve types, and outcomes in the Society of Thoracic Surgeons National Database, J Thorac Cardiovasc Surg, 137, 82, 10.1016/j.jtcvs.2008.08.015 Kappetein, 2013, Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document, J Thorac Cardiovasc Surg, 145, 6, 10.1016/j.jtcvs.2012.09.002 Campisi, 2014, Early failures of Trifecta aortic bioprosthesis, J Thorac Cardiovasc Surg, 148, e133, 10.1016/j.jtcvs.2014.03.018 Saxena, 2014, Early structural valve deterioration of the Trifecta aortic valve biological prosthesis: a word of caution, J Thorac Cardiovasc Surg, 147, e10, 10.1016/j.jtcvs.2013.07.053 Hamamoto, 2017, Pure cusp tear of Trifecta bioprosthesis 2 years after aortic valve replacement, Ann Thorac Cardiovasc Surg, 23, 157, 10.5761/atcs.cr.16-00183 Mosquera, 2016, Long-term outcomes and durability of the Mitroflow aortic bioprosthesis, J Card Surg, 31, 264, 10.1111/jocs.12726 Ius, 2017, Long-term results of the Mitroflow aortic pericardial bioprosthesis in over 800 patients: limited durability and mechanisms of dysfunction, Eur J Cardiothorac Surg, 52, 264, 10.1093/ejcts/ezx161 Senage, 2014, Early structural valve deterioration of Mitroflow aortic bioprosthesis: mode, incidence, and impact on outcome in a large cohort of patients, Circulation, 130, 2012, 10.1161/CIRCULATIONAHA.114.010400 Glaser, 2014, Late survival after aortic valve replacement with the Perimount versus the mosaic bioprosthesis, Ann Thorac Surg, 97, 1314, 10.1016/j.athoracsur.2013.10.078 You, 2016, Aortic valve replacement with Carpentier-Edwards: hemodynamic outcomes for the 19-mm valve, Ann Thorac Surg, 101, 2209, 10.1016/j.athoracsur.2015.11.016 Dalmau, 2007, One year hemodynamic performance of the Perimount Magna pericardial xenograft and the Medtronic Mosaic bioprosthesis in the aortic position: a prospective randomized study, Interact Cardiovasc Thorac Surg, 6, 345, 10.1510/icvts.2006.144196 Modi, 2014, Early in-vivo hemodynamic comparison of supra-annular aortic bioprostheses: Trifecta versus Perimount Magna Ease, J Heart Valve Dis, 23, 325 Matsumoto, 2015, Hemodynamic performance and durability of Mosaic bioprostheses for aortic valve replacement, up to 13 years, Circ J, 79, 1044, 10.1253/circj.CJ-14-0990 Smith, 2011, Transcatheter versus surgical aortic-valve replacement in high-risk patients, N Engl J Med, 364, 2187, 10.1056/NEJMoa1103510 Reardon, 2017, Surgical or transcatheter aortic-valve replacement in intermediate-risk patients, N Engl J Med, 376, 1321, 10.1056/NEJMoa1700456 Goldman, 2017, Midterm, multicenter clinical and hemodynamic results for the Trifecta aortic pericardial valve, J Thorac Cardiovasc Surg, 153, 561, 10.1016/j.jtcvs.2016.09.089 Anselmi, 2017, Mid-term durability of the Trifecta bioprosthesis for aortic valve replacement, J Thorac Cardiovasc Surg, 153, 21, 10.1016/j.jtcvs.2016.07.080 Bach, 2016, Randomized comparison of exercise haemodynamics of Freestyle, Magna Ease and Trifecta bioprostheses after aortic valve replacement for severe aortic stenosis, Eur J Cardiothorac Surg, 50, 361, 10.1093/ejcts/ezv493 Colli, 2016, The TRIBECA study: Trifecta bioprosthesis evaluation versus Carpentier Magna-Ease in aortic position, Eur J Cardiothorac Surg, 49, 478, 10.1093/ejcts/ezv070 Yadlapati, 2014, Comprehensive hemodynamic comparison and frequency of patient-prosthesis mismatch between the St. Jude Medical Trifecta and Epic bioprosthetic aortic valves, J Am Soc Echocardiogr, 27, 581, 10.1016/j.echo.2014.01.002